This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Raptor Pharmaceutical Corp (RPTP)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Aug 2012 Aug 2011
Cash Flow From Operating Activities
Net Income (Loss) -69.42M -19.29M 0.00 -37.19M
Operating Gains/Losses 116.00K 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -6.18M 0.00 0.00 0.00
(Increase) Decrease in Inventories -3.00M 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -114.00K 3.08M 754.00K 209.82K
(Decrease) Increase In Other Current Liabilities 10.39M -502.00K 403.00K 1.12M
(Increase) Decrease In Other Working Capital 4.92M 71.00K -10.00K 19.46K
Other Non-Cash Items 17.78M 3.79M -30.01M 18.53M
Net Cash From Continuing Operations -46.60M -11.26M -31.35M -17.22M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -46.60M -11.26M -31.35M -17.22M
Sale of Property, Plant & Equipment 27.00K 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 22.11M 0.00 30.00M 0.00
Purchases of Property, Plant & Equipment -2.85M -55.00K -378.00K -49.42K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -147.00K -6.85M -45.31M 0.00
Other Cash from Investing Activities -337.00K 6.00K -54.00K -114.47K
Cash Provided by Financing Activities
Net Cash From Investing Activities 18.80M -6.90M -15.74M -163.89K
Issuance of Debt 25.00M 25.00M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 12.80M 8.19M 59.06M 15.75M
Repayment of Long-Term Debt -10.00K -2.00K -5.00K -4.86K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 37.01M -2.23M -3.51M -151.78K
Net Cash From Financing Activities 74.80M 30.96M 55.55M 15.59M
Effect of Exchange Rate Changes -268.00K -65.00K -52.00K 9.76K
Net Change in Cash & Cash Equivalents 46.74M 12.73M 8.41M -1.78M

RPTP Raptor Pharmaceutical Corp

Analysts Ratings for RPTP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1

Brokerage Partners

RPTP Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs